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Abstract
Purpose—The present study defines genomic loci underlying coordinate changes in gene
expression following retinal injury.
Methods—A group of acute phase genes expressed in diverse nervous system tissues was defined
by combining microarray results from injury studies from rat retina, brain, and spinal cord. Genomic
loci regulating the brain expression of acute phase genes were identified using a panel of BXD
recombinant inbred (RI) mouse strains. Candidate upstream regulators within a locus were defined
using single nucleotide polymorphism databases and promoter motif databases.
Results—The acute phase response of rat retina, brain, and spinal cord was dominated by
transcription factors. Three genomic loci control transcript expression of acute phase genes in brains
of BXD RI mouse strains. One locus was identified on chromosome 12 and was highly correlated
with the expression of classic acute phase genes. Within the locus we identified the inhibitor of DNA
binding 2 (Id2) as a candidate upstream regulator. Id2 was upregulated as an acute phase transcript
in injury models of rat retina, brain, and spinal cord.
Conclusions—We defined a group of transcriptional changes associated with the retinal acute
injury response. Using genetic linkage analysis of natural transcript variation, we identified
regulatory loci and candidate regulators that control transcript levels of acute phase genes.
To understand the global consequences of retinal injury, several laboratories monitored the
transcriptome with microarray techniques [1–5]. These changes in transcripts were analyzed
to define the key regulatory events following retinal injury. In an earlier study, we defined a
temporal grouping of changes related to the biochemical and cellular response to retinal injury
[1]. This type of analysis, defining gene clusters that occur after injury, is not an endpoint in
the analysis but a beginning. The growing number of bioinformatic resources provides an
opportunity to further analyze and interpret the changes in the transcriptome after retinal injury.
We can now examine the transcriptome data from injured retina by using not only various
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injury models [1–5] but also combining data from different regions of the central nervous
system (CNS [6–9]).
Our previous analysis of rat retina identified three major transcript phases after injury: an early
acute phase (within an hour), an intermediate subacute phase (within 1 to 2 days), and a late
chronic phase (within 3 days to weeks [1]). The early acute phase is characterized by the
transient upregulation of immediate-early genes, mainly transcription factors and activating
cytokines. The intermediate subacute phase is characterized by the expression of cell-cycle
and cell death genes. The late chronic phase is characterized by the expression of genes
involved in neuronal and glial structural remodeling. Similar changes were described in injury
models in the rat retina [2–5], brain [6,7], and spinal cord [8]. For example, the early acute
genes Fos, Jun, Egr1, and Nfkb1 as well as the late chronic genes Gfap, A2m, Apoe, and
Hsp27 display transcript changes resulting from virtually any trauma or stress throughout the
CNS [1–8]. The similarities of coordinate changes in the retina, brain, and spinal cord indicate
the presence of common transcriptional networks controlling the CNS response to injury.
GeneNetwork [9–12] is a powerful analytical tool to define transcriptional networks and
regulators in CNS tissues. At the heart of this analysis is a unique population of mice, the
recombinant inbred (RI) strains of mice. These strains were derived by inbreeding for over 20
generations the F1 crosses between C57BL/6 (B) and DBA/2J (D) mouse strains. Each BXD
RI strain has a shuffled genome consisting of a unique recombination of the C57BL/6 and
DBA/2J genomes, forming a segregating population of mice. These RI mouse strains, the
associated microarray databases, and the genetic-analysis tools at GeneNetwork allow one to
explore regulatory loci and networks built around any transcript [9–12]. The best way to think
about the genetic linkage mapping is at the transcript level. If there is specific variability in
transcript abundance among members of a segregating population, then it is possible to map
transcript abundance to a specific chromosomal locus [9,10]. One example of this type of
analysis was presented by Chesler and colleagues [9] where a group of genes involved in
synaptic vesicle regulation forms a network with distinct regulatory loci. The concept of genetic
analysis of transcript data is called “expression genetics” or “genetical genomics” [13]. Of
interest to the vision community is the comprehensive analysis of regulatory loci controlling
gene expression of the mouse brain. Both retina and brain are tissues derived from the neural
tube. Thus, they share similar cell types with similar transcriptional regulation. For example,
the transcription factor STAT3 plays an important role in activating cortical astrocytes [14]
and retinal Müller glial cells [15]. Thus, it may be possible to use available genetic analyses
of brain transcript data to define genetic networks and regulatory loci for the rat retina. To
identify genomic loci and potential candidate genes controlling changes in the rat retina, we
turned to our publicly available database, GeneNetwork. The GeneNetwork database was
generated using RI mouse strains and a similar data set is not currently available for the rat.
Since the rat is closely related to the mouse and since transcriptional expression in the normal
and injured CNS is highly conserved across rodent species [16], we have chosen to use this
mouse database to further analyze the changes in gene expression that occur following injury
to the rat CNS.
Here we describe a method to define regulators of retinal wound healing that uses published
and publicly available microarray data, transcript regulatory loci databases, and bioinformatic
resources. As a starting point, we define regulators that control the expression of acute phase
genes after a mechanical injury to the rat retina [1]. First, to eliminate retina-specific genes and
to increase the power of our analysis, we extract a group of acute phase genes that are common
to injured rat retina, brain, and spinal cord. Second, we determine the regulatory loci controlling
the expression of acute phase genes in mouse brains using GeneNetwork. Third, we use
computational tools to predict a candidate upstream regulator.
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METHODS
Meta-analyses of microarray data sets
We performed a meta-analysis of previous experimental data (Table 1) to select a group of
candidate genes for a common response to injury in neural tissues. We previously published
CNS microarray analyses that examined the transcriptome response of injured rat retina and
brain, the transcriptome of cultured human and rat astrocytes, and the regulatory loci
controlling transcript expression in the mouse brain [1,6,7,9,11,17]. To complement our
analysis of reactive CNS genes, we obtained publicly available microarray analyses that
examined the transcriptome response of injured rat spinal cord, the transcriptome of developing
mouse retina, and the transcriptome of cultured mouse neurons, mouse astrocytes, and rat
microglia [8,18–21]. Table 1 makes clear the source and availability of each microarray data
set. The use of microarray datasets involved three different meta-analyses. First, a set of acute
phase genes commonly expressed throughout the CNS was defined by directly comparing
microarray data from injured rat retina, brain, and spinal cord. For this analysis, we obtained
the raw data (CEL files), determined signal values using Microarray Suite 5.0 (MAS 5.0;
Affymetrix, Santa Clara, CA), transformed signals to a log scale (base 2), and normalized
microarray mean intensity to 8 as described previously [1]. These transformations yielded
signal intensities ranging from 1 to 18 relative units of fluorescence. Further analyses included
only transcripts with medium to high abundance (that is, signals greater than 8.64) [1]. To
determine significant differences, we used Student’s t-test (p<0.05) and changes greater than
2 fold. The second meta-analysis determined if an acute phase gene was expressed in cultured
astrocytes, cultured microglia, cultured neurons, and in the developing retina. An acute gene
was considered present in a tissue if it displayed medium to high abundance [1]. In the third
meta-analysis, we used GeneNetwork to examine transcript regulation in mouse forebrains.
Transcriptome analyses with Affymetrix RG-U34A and MG-U74Av2 survey about nine and
twelve thousand targets (about 30 and 40% of the rodent transcriptome, Affymetrix database,
June 2005 Annotation).
Online regulatory locus analyses
To define regulatory loci that control gene expression in mouse brain, we used GeneNetwork,
which is maintained by members of our group (EJC, LL, KFM, and RWW). Details on the
methods, data, and analyses are available at GeneNetwork [9–12]. Briefly, GeneNetwork is a
suite of databases and analysis software that identifies regulatory loci that control transcript
abundance of nearly 12,000 genes in a panel of 32 BXD RI mouse strains derived from C57BL/
6 (B) and DBA/2J (D) mice, both parental strains, and the F1 hybrid (a total of 35 isogenic
lines) [9–12]. Strain means for transcript abundance were generated from three to five
Affymetrix U74Av2 microarrays, and each individual array was hybridized to a pool of
forebrain tissue taken from three adult animals [9,11]. To maximize strain-dependent
expression variance or heritability, probe-set signals were measured by weighting the perfect-
match (PM) probes by their heritability [22]. Using quantitative genetic analysis and a genetic
map consisting of 779 fully genotyped markers, GeneNetwork correlates the mean abundance
of each transcript to genotypes at locations throughout the mouse genome. The average distance
between adjacent markers is approximately 4 megabases (Mb). Here, we examined the
regulation of acute phase genes in mouse brains using GeneNetwork and the weighted-by-
heritability transforms (UTHSC Brain mRNA U74Av2 HWT1PM; December 2003).
Variability across strains was measured using an analysis of variance (ANOVA) testing the
between-strain variance compared with the total variance for 100 arrays from 35 mouse strains.
The degrees of freedom for the between-group and total variance are 34 and 99. Strain-specific
variation is significant (p<0.05) when F34,99>1.5. Whole genome maps for all transcripts are
replicated and recomputed using a variety of transforms and analytical methods in
GeneNetwork, including simple and composite interval mapping, multiple-trait clustering, and
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principal component analysis. We also confirmed the strength of a candidate upstream
regulator using the cerebellum GeneNetwork database (SJUT Cerebellum mRNA M430
MAS5; January 2004). Since gene names may differ across species and multiple probe sets
may be available in the U74Av2 microarray, we include the probe set identifier when referring
to genes analyzed with GeneNetwork. We confirmed gene identity of a probe set using the
Affymetrix (June 2005 Annotation) and Ensembl AffyProbe (v33) databases.
Online bioinformatic resources
To identify candidate genes within a regulatory locus, we located genes within the appropriate
genomic interval using the Genome Browser (GenomeBrowser) Mouse (May 2004 assembly).
Single nucleotide polymorphisms (SNPs) were identified by comparing genome sequences in
the Celera SNP (Celera Discovery Systems, CA; July 2003 Assembly), Ensembl Mouse
SNPView (v33), and Entrez SNP (EntrezSNP) databases. Once the SNPs were identified, a
computational approach was used to determine if the SNP within the Id2 promoter (rs4229289,
for sequence variation and genomic context see Ensembl Mouse SNPView) was within a
transcription factor binding site. First, we determined whether the rs4229289 SNP was located
within a highly conserved region using Genome Browser Conservation tool (Mouse May 2004
Assembly). Second, we obtained a highly conserved sequence around the rs4229289 SNP from
the alignment of mouse, rat, and human sequences using Genome Browser Conservation tool
(May 2004 Assembly). Alignments with other species were not available. Third, we located
putative transcription factor binding sites within the conserved region using the vertebrate
TRANSFAC database available through MOTIF database and using the default cutoff score
[23].
Several online databases provide transcript data or transcript distribution in the CNS. Gene
Expression Omnibus (GEO) is a high-throughput gene expression abundance data repository,
as well as a curated, online resource for gene expression data browsing, query, and retrieval.
Retina Developmental Gene Expression (RetDevGE) describes the gene expression profile of
thousands of genes in the developing post-natal mouse retina that were analyzed by
hybridization to Affymetrix Mu74 Av2 [21]. Mouse Retina SAGE (MouseRetSAGE) Library
provides serial analysis of gene expression tags or in situ hybridization images for a limited
number of transcripts expressed in the developing and adult mouse retina [24]. Gene Expression
Nervous System Atlas (GENSAT) maps the transcript distribution in the mouse CNS using in
situ hybridization.
RESULTS
Acute phase genes
In our continuing efforts to understand the retinal response to injury, we concentrated on the
transcriptome changes that occur within hours after retinal injury: the acute phase genes. We
know that there is a sequence of changes leading to reactive gliosis and remodeling of the retina
[1]. To make our analysis more robust and generalized for CNS injury, we combined our injured
rat retina data with results from injured rat brain and spinal cord. In these three data sets, 30
genes demonstrated a significant change in expression level (Table 2; p<0.05; change>2 fold
4 h after injury). All of the common changes in the three data sets were upregulated after injury.
No common downregulated transcripts were observed in injured retina, brain, and spinal cord.
These acute phase genes can be expressed in a wide range of neural cells including astrocytes,
microglia, and neurons (Table 2). These results suggested a generalized group of transcript
changes that occurs in the CNS after injury.
The acute phase genes belong to several transcript categories including transcription, cytokines,
cell adhesion, extracellular proteases, and metabolism. The major transcript group (46.6%)
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was related to the regulation of gene expression including transcription factors and transcription
modulators. Based on gene expression dynamics, acute phase genes displayed either transient
or chronic expression changes after retinal injury (Table 2). For example, transcription factors
such as Crem, Egr1, Fos, Fosl1, Junb, Egr1, Ier3, Btg2, Atf3, and Nr4a1 were upregulated,
with a transient surge at 4 h. Other transcription factors such as Irf1, Stat3, Nfkb1, Id2, and
Cebpd displayed an upregulation at 4 h, followed by a smaller, but sustained, expression out
to 30 days after retinal injury (Table 2).
Regulatory locus analyses
The grouping of genes with similar transcript expression changes suggested the presence of
common upstream modulators. To begin defining regulatory mechanisms controlling the
retinal injury response, we tested the hypothesis that acute phase genes share common
regulatory loci (Figure 1). Transcriptome-wide regulatory loci for the mouse brain were
mapped previously by our group [9,11] and can be replicated and recomputed using the
databases and genetic analysis tools at GeneNetwork. We used the mouse brain transcriptome
and genetic analysis at GeneNetwork to define common regulatory loci for acute phase genes.
A genome-wide scan estimates the association of transcript abundance variability against
genetic markers across the mouse genome. For example, the abundance variability of Id2 was
high in brains from BXD RI mouse strains (F34,99=5.2; probe set 93013_at for Id2 mRNA). In
the genome-wide scan (Figure 1A), the correlation of Id2 variability across the mouse genome
is indicated by the likelihood ratio statistic curve (LRS; blue line). At Chromosome 12, 10–30
Mb distal to the centromere, Id2 variation correlated highly with genetic markers
D12Mit209, D12Nyu7, Rrm2, D12Mit234, and D12Mit242 (Figure 1A, LRS=44). In a second
example, Fos displayed variation (F34,99=1.5; probe set 160901_at) that also correlated with
genetic markers that span a region of Chromosome 12 at 10–30 Mb (Figure 1A, LRS=13). The
correlation of Fos and Id2 expression to a chromosomal interval on Chromosome 12 suggested
that this locus contains one or more polymorphic genes that affect the levels of both transcripts.
In the group of acute phase genes, a number of transcripts had a common regulatory locus on
Chromosome 12. These included Fos, Nr4a1, Id2, Egr1, Crem, Junb, Ccl3, and Ptpn16, all of
which shared a strong correlation to the locus on Chromosome 12, 10–30 Mb (Figure 1B,
LRS>10; probe sets 160901_at, 102371_at, 93013_at, 98579_at, 160526_at, 102362_at,
102424_at, and 104598_at, respectively). By aligning genome-wide scans, we identified a
strong band of regulatory loci (Figure 1B). Most of the genes (Fos, Nr4a1, Egr1, Crem,
Junb, Ccl3, and Ptpn16) regulated by this genomic location are found outside the regulatory
locus, termed “trans-regulatory locus.” One of the genes, Id2, lies within the regulatory locus
(orange arrowhead, Chromosome 12 at 20.1 Mb; Figure 1). This is termed a “cis-regulatory
locus” for Id2. Transcripts genetically linked to the same regulatory locus are part of a genetic
network [9]. In this case, Fos, Nr4a1, Id2, Egr1, Crem, Junb, Ccl3, and Ptpn16 are part of a
genetic network that is controlled by the regulatory locus on Chromosome 12, 10–30 Mb. In
addition to the regulatory locus on Chromosome 12, we identified two additional loci that may
regulate transcript levels of acute phase genes (Figure 2). These regulatory loci were located
on Chromosomes 6 and 14. In some cases, transcripts correlated to multiple regulatory loci.
For example, Fos and Nr4a1 were genetically linked to regulatory loci on Chromosomes 6 and
12, whereas, Nfkb1 and Scya2 correlated with regulatory loci on Chromosome 6 and
Chromosome 14. The genetic relationships between transcript variation and genomic loci
defined three genetic networks controlling the expression of acute phase genes in mouse
forebrains (Figure 2). The regulators for these genetic networks are located within the
regulatory loci on Chromosomes 6, 12, and 14.
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Evaluating candidate upstream regulators
Once a regulatory locus was identified, the third step in our analysis refined the genomic
location responsible for the mapping to this chromosomal interval. Within each regulatory
locus, a genomic element generates the variation in expression of acute phase genes.
Ultimately, the genomic differences between the C57BL/6 and DBA/2J mice underlie the
transcript abundance variability observed in BXD RI mouse strains. Since the BXD RI mouse
strain haplotypes are finely mapped and the parental genomes are sequenced, we have thorough
SNP maps for the 35 strains [9]. SNPs affecting the expression of acute phase genes may be
found in a number of genomic elements including promoters, enhancers, exons, or introns.
These genomic elements may affect the transcript levels of the upstream regulator. Hundreds
or even thousands of SNPs may lie within a regulatory locus. Using simple rules helps to select
a candidate gene. For example, a candidate gene lies within the regulatory locus, displays SNPs,
and is functionally relevant to the genes correlating to the regulatory locus. Biological
significance of SNPs can be queried using programs that predict whether SNPs affect known
DNA binding sites or protein sequence motifs [23]. The vast biological content within online
resources provides a powerful tool to identify the regulatory element controlling the expression
of genes within a biological pathway, in our case the response of the transcriptome to retinal
injury. We present our analysis of candidate regulators for several of the loci. We conclude
with evidence for a strong candidate gene for the regulatory locus on Chromosome 12.
The regulatory locus on Chromosome 14, 35–65 Mb, modulates the transcript variability of
transcription factors Stat3, Nfkb1, and Irf1; cytokines Il1b and Scya2; and development-related
gene Adfp (Figure 3A, probe sets 102736_at, 103486_at, 161281_f_at, 161443_r_at, 93858_at,
98427_s_at, and 99099_at). This is a trans-regulatory locus for these genes, as they all lie
outside this locus. A genomic element within the locus is a trans-regulator for these acute phase
genes. Within this locus, there were 315 positional candidate genes (Figure 3B,C). A simple
procedure to weigh the relevance of a positional gene is to determine whether it displays
significant transcript variability in BXD RI mouse strains and whether its variability maps to
its gene location: That is, does the gene display a cis-regulatory locus? Highly variable
transcripts included Rnase4, AW045965, M6a, Boct, Dad1, Ctsb, Cnih, and Ndrg2 (F34,99>4).
Of these, Rnase4, AW045965, M6a, Boct, Boct, Cnih, and Ndrg2 linked strongly to the
regulatory locus on Chromosome 14 (LRSs>17; Figure 3D; data for Ndrg2 shown, probe set
96088_at). To further evaluate the role of these positional genes, we determined whether their
self-regulatory role extended to the cerebellum of BXD RI mouse strains. Rnase4,
AW045965, M6a, and Ndrg2 displayed significant cis-regulatory loci on Chromosome 14, 35–
65 Mb (LRSs>12, data not shown; probe sets 96038_at, 100073_at, 104456_at, and
161610_at). These data suggested that the regulatory role of the locus on Chromosome 14 is
conserved across CNS tissues. Rnase4, AW045965, M6a, and Ndrg2 are candidate upstream
regulators because they display cis-regulatory loci.
Identifying the genes with SNPs also helps to identify the candidate upstream regulator. The
sequences for Rnase4, AW045965, M6a, and Ndrg2 had multiple SNPs between the C57BL/
6 and DBA/2J strains. For example, Ndrg2 had a high density of SNPs: 7 within the promoter
(Celera SNPs IDs mCV23555818, mCV23556083-5, mCV23556089-91), and 25 within exons
and introns (Celera SNPs IDs mCV23555752, 756-8, 762-3, 768-70, 774-6, 780-1, 788, 792-4,
804-6, 811-2, 816-7). The presence of SNPs further supported the role of Rnase4,
AW045965, M6a, and Ndrg2 as candidate upstream regulators. The use of transcriptome data
from developing mouse retina [21,24] or injured rat retina [1] can be valuable in determining
whether a candidate gene plays a role in controlling acute phase genes in the retina. In murine
models of retinal development [21,24], Ndrg2 displayed moderate transcript levels as early as
postnatal day 4 and was expressed in the adult retina (Figure 3E; data available at RetDevGE
[21] and MouseRetSAGE Library [24]). In contrast, Rnase4, AW045965, and M6a were absent
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from birth through adult retinal stages (data available at RetDevGE). Using a suite of
computational tools and transcriptome data from CNS gene regulation and development, we
defined Ndrg2 (N-myc downstream regulated gene 2) as a positional candidate that displayed
a cis-regulatory locus in the mouse brain and cerebellum and that has a high SNP density. At
the present time, Ndrg2 is the best candidate gene for the regulatory locus on Chromosome 14
and for potentially being a regulator of retinal acute genes. Ndrg2 displays a conserved self-
regulatory role in mouse brain and cerebellum. It is expressed in the developing mouse retina
during the critical time of cell proliferation and cell specification. It is expressed in the
developing mouse retina during the critical time of cell proliferation and cell specification. It
displays persistent transcript expression in the adult mouse retina.
The regulatory locus on Chromosome 6 at 105–132 Mb also controls the expression of acute
phase genes such as Fosl1, Scya2, Nr4a1, Fos, Nfkb1, Icam1, and Timp1 (Figure 4A; probe
sets 102371_at, 102736_at, 160901_at, 99835_at, 101141_at, 98427_s_at, and 101464_at).
Within the locus, there were 315 positional genes (Figure 4B). Using the computational and
comparative techniques described above, Ccnd2 (Cyclin D2) best met the criteria for a
candidate upstream regulator. Ccnd2 displayed significant transcript abundance variability
(F34,99=3.8, Figure 4C, probe set 97504_at) and a strong cis-regulatory locus on Chromosome
6 (LRS=29, Figure 4D) in brains from BXD RI mouse strains. We also observed a strong cis-
regulatory locus for Ccnd2 in the cerebellum (LRS=15; probe set 1416122_at_A; data not
shown). Multiple SNPs spanned the transcribed region of Ccnd2 (Celera SNP IDs
mCV24153285, 558, 560, 570, 580-2, 592-4, 615-6). These data suggested that Ccnd2 might
control the expression of classic acute genes in the CNS of BXD RI mouse strains. In the mouse
retina, Ccnd2 is expressed during development and adult stages (data available at Mouse Retina
SAGE Library and GENSAT Image 14340). Moreover, Ccnd2 displayed chronic upregulation
in the injured rat retina (data available at GEO data set GSE1001, probe set rc_AA899106_at
[1]). Several data defined Ccnd2 as the best current candidate gene for the regulatory locus on
Chromosome 6 and for potentially being a regulator of retinal reactive genes. It displays
conserved self-regulatory role in mouse brain and cerebellum. It is expressed in the developing
mouse retina during the critical time of cell proliferation and cell specification. It is expressed
in the developing mouse retina during the critical time of cell proliferation and cell
specification. It displays chronic upregulation in the injured rat retina.
For the network defined by the regulatory locus on Chromosome 12 (Figure 5A, probe sets
93013_at, 161802_i_at, 161716_at, 160526_s_at, 104598_at, 102424_at, 102371_at, and
102362_i_at), the Inhibitor of DNA binding 2 (Id2) is the best current candidate upstream
regulator. First, the positional candidate Id2 (Figure 5B; probe set 93013_at) showed significant
variability and strong cis-regulatory locus in brains from BXD RI mouse strains (F34,99=5.2,
Figure 5C; and LRS=44; Figure 5D). In the cerebellum, we also observed a strong cis-
regulatory locus for Id2 (LRS=13; probe set 1453596_at_A; data not shown). Second, while
several cis-regulated genes were located within the regulatory locus on Chromosome 12 (for
example, Lpin1 [probe set 98892_at]), only Id2 was upregulated in the rat retina, brain, and
spinal cord after injury (Table 2). In the injured rat retina, Id2 also displayed a chronic
upregulation even after 30 days postinjury (Table 2; data available at GEO data set GSE1001,
probe set rc_AI230256_at). Id2 was also highly expressed during mouse retinal development
at the time of high levels of cell proliferation and remained present in the adult mouse retina
(data available at Retina Developmental Gene Expression and Mouse Retina SAGE Library).
Third, we located one SNP for Id2 within the promoter and four SNPs within the second intron
(Figure 5D; Ensembl gene ID ENSMUSG00000020644). An SNP within the promoter region
of Id2 may alter the ability of a transcription factor to modulate Id2 transcription.
We used in silico promoter analysis to define the transcription factor binding site affected by
the SNP (Ensembl SNPView ID rs4229289 and Celera SNP ID mC22302957). Located 320
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base pairs upstream of the starting codon, the SNP consisted of an adenine-guanine (A/G)
substitution between the DBA/2J and C57BL/6. The SNP was also located in a highly
conserved region across mouse, rat, and human orthologs (Figure 5F). Using the MOTIF
database, we determined that the SNP sits next to a CCAAT binding site (TRANSFAC ID
M00254), a likely binding site for nuclear transcription factor (NF)-Y (TRANSFAC ID
M00185). Based on the TRANSFAC 5.0 database available through the MOTIF website, NF-
Y binds to the CCAAT motif when the adjacent 3′-nucleotide is either G or C as seen in the
C57BL/6, rat, and human sequences for Id2 (Figure 5F). The nucleotide substitution of an A
for a G/C may account for the lower Id2 levels seen in the DBA/2J and in all the BXD strains
carrying the DBA/2J haplotype. Several lines of evidence indicate that Id2 is a good candidate
gene for the regulatory locus on Chromosome 12. Id2 is conserved and has a self-regulatory
role in mouse brain and cerebellum. It is expressed in the developing retina during the critical
time of cell proliferation and cell specification. It is upregulated immediately following injury
to rat retina, brain, and spinal cord.
DISCUSSION
Discovering mechanisms controlling retinal wound healing from gene expression data is a
promising and challenging task. The method of extracting genetic networks and gene regulation
presented here involves (1) highlighting robust injury genes in multiple models of CNS trauma,
(2) defining regulatory loci using genetic analysis of transcript data (that is, expression genetics
[13]) from CNS tissues, and (3) predicting candidate regulators using bioinformatic resources
that are available online. Using this approach, we defined a set of acute phase genes that is
commonly expressed in the retina, brain, and spinal cord after traumatic injury. Our expression
genetic analyses revealed that regulatory loci on Chromosomes 6, 12, and 14 control the
expression of acute phase genes in brains from BXD RI mouse strains. With the help of an
array of online bioinformatic tools, we identified three genetic networks and candidate
upstream regulators: Ndrg2, Ccnd2, and Id2.
Surprisingly, the changes controlled by these three loci are present in a variety of different
CNS tissues: retina, brain, and spinal cord. This begs the question, are the networks controlled
by the loci on Chromosomes 6, 12, and 14 unique to the CNS? If one examines normal tissues,
these regulatory loci appear to be unique to the CNS. For example, expression genetics of
hematopoietic stem cells from BXD RI mouse strains showed completely different sets of
regulatory loci [10]. This is not surprising given the difference in expression patterns between
CNS tissues and hematopoietic stem cells [9,10]. The same is true of the liver where Schadt
and colleagues [25] identified a different set of regulatory loci that did not correlate with our
observations in the CNS. Although the specificity of expression-related regulatory loci in CNS,
hematopoietic stem cells, and liver are different in normal resting conditions, we cannot
exclude the possibility that some regulatory mechanism are similar following trauma. Based
upon our current data, the loci identified at chromosomes 6, 12, and 14 appear specific to the
CNS.
Our method complements approaches that identify modules of co-regulated genes, shared
cis-regulatory motifs, and transcriptional factors binding to cis-regulatory motifs [26]. In
reality, transcriptome changes during the wound-healing response are controlled by a much
more complex network [27–30]. Our method holds the potential for identifying members of
genetic networks and regulators that may include gene products involved in mRNA stability,
heterochromatin remodeling, transcriptional repression, and other regulatory mechanisms [9–
12,25]. Indeed, even indirect modifiers of the transcriptional response to injury that are not
transcription factors can be identified using a genetic approach. Our analysis suggests, for
example, that the expression of acute phase genes is genetically linked to the transcript
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expression of three non-transcription factors including the hydrolase NDRG2, the cyclin
CCND2, and the dominant negative helix-loop-helix protein ID2.
Key to defining modulators of regulatory networks in BXD RI mouse strains is the genetic
differences between parental strains. Genetic differences between C57BL/6 and DBA/2J
strains provide a powerful system to study regulators and their targets, but this approach is
limited to the detection of polymorphisms between these strains. For some genes believed to
be involved in the response of the CNS to injury there are no genetic differences between the
BXD parental strains. For example, STAT3 (a potent activator of acute phase genes such as
Fos [31,32]) has no SNPs in the coding or regulatory regions when the sequence of Stat3 of
C57BL/6 strain is compared to that of the DBA/2J strain. Consequently, expression genetics
of BXD RI mouse strains revealed no genetic linkage between the Stat3 locus and genes known
to be associated with its regulation such as Fos. To provide a fuller examination of the networks
controlling retinal wound healing the BXD RI strains can be supplemented by studying
additional strains. Other RI strains of mice can be equally valuable. The BXA and AXB RI
strains were produced from crosses of the C57BL/6 (B) and A/J (A) mouse strains. Genetic
differences between these two strains can be used to map different regulatory loci. One prime
example of the use of the AXB RI strains comes from a study of horizontal cell density. A 2
fold difference in horizontal cell density was observed between C57BL/6 and A/J mouse strains
[33]. The genetic backgrounds of the A/J mouse strains and RI strains derived from the C57BL/
6 and A/J mouse strains make it possible to map genetic loci controlling horizontal cell number
and potentially the response of horizontal cells to retinal injury. Undoubtedly as more
genetically diverse sets of strains become available, transcriptome-wide analysis combined
with genetic analysis will yield additional regulatory loci. This type of analysis and the
development of additional expanded RI strains of mice hold great promise in the search for
genetic networks controlling complex biological processes such as wound healing in the retina
and CNS.
Typically, a candidate upstream modulator within regulatory loci will display (1) high
transcript variation that maps onto its transcript location, that is, a cis-regulatory locus, (2)
polymorphisms between parental strains, and (3) a function related to CNS disease or
expression changes after CNS injury. Ndrg2, Ccnd2, and Id2 met the candidate gene criteria
for the regulatory loci on Chromosomes 14, 6, and 12, respectively. N-myc downstream
regulated gene 2 (NDRG2) is found at high protein levels in neurogenic regions of the adult
rat brain. In these regions, NDRG2 localizes to GFAP-positive astrocytes or radial glia [34].
In humans, downregulation of Ndrg2 is associated with glioblastoma [35]. High levels of
NDRG2 are often associated with senile plaques of Alzheimer’s patients and cellular processes
of dystrophic neurons [36]. Our meta-analyses of Ndrg2 using transcript data from developing
mouse retina showed that Ndrg2 was expressed during the time of cell proliferation and cell
specification. These data suggest that NDRG2 may play a key role in the proliferation of glia
cells and the degeneration of neurons.
A second likely upstream candidate of CNS injury is cyclin D2 (CCND2). Cyclin D2
phosphorylates the Rb protein of the RB-E2F complex. Cyclin D2 binding to the Rb protein
allows the transcription factor E2F to enter the nucleus and stimulate proliferation. During the
development of the cerebellum, cyclin D2 is a marker of proliferating granule cell precursors.
Granule neurons are the principal neuronal component of cerebellum, and mice deficient in
cyclin D2 show decreases in the number of granule cells and stellate interneurons [37,38]. Our
meta-analyses of Ccnd2 also indicated that Ccnd2 was moderately expressed in cultured
astrocytes from the cortex and optic nerve, in the mouse developing retina, and injured rat
retina. The enhanced expression of cyclin D2 in the retina following trauma may contribute to
reactive responses such as cellular proliferation.
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The third and most promising upstream candidate of CNS injury is the inhibitor of DNA binding
2 (ID2). Our analyses suggest that changes in Id2 expression were a common theme in many
reactive CNS tissues. Based on our meta-analyses of microarray data, Id2 was upregulated in
rat retina, brain, and spinal cord after mechanical injury. In rat models of glaucoma [3], the
dystrophic retina also upregulates Id2 (personal communication, Drs. Farid Ahmed and
Stanislav Tomarev, NEI, NIH). We have confirmed upregulation of Id2 transcript in mouse
retina after a mechanical and toxic injury (data not shown). Optic nerve head astrocytes from
patients suffering glaucoma display higher Id2 transcript levels than astrocytes from non-
glaucomatous patients [39]. The role of ID2 as a positive regulator of cell-cycle progression
[40–42] is consistent with the proliferative response that occurs in retinal injury. A potential
source for dividing cells in the inner nuclear layer is the Müller cells [43–45]. When Müller
cells enter the cell cycle, they decrease the expression of cell cycle inhibitors, including the
cyclin-dependent kinase inhibitor p27/Kip1 [43]. ID2 is known to negatively regulate the
transcription of cell cycle inhibitor genes, including p15, p16, and p21 [40]. ID2 downregulates
expression of cell cycle inhibitors by preventing the interaction of basic helix-loop-helix
(bHLH) transcription factors that promote the transcription of cell cycle inhibitor genes [40].
Alternatively, ID2 may stimulate proliferation by binding to the unphosphorylated Rb protein,
allowing the release of the transcription factor E2F. E2F in turn activates genes involved in the
G1 to S transition and hence proliferation [40,41]. Re-entry into the cell cycle may also indicate
apoptotic activity [46]. ID2 is known to play a role in neuronal apoptosis [47]. Cerebellar
granule neurons upregulate transcript and protein levels of ID2 during the onset of apoptosis
[47]. The expression of Id2 antisense RNA in neurons protects from apoptosis. Together these
data suggest that the increase in ID2 may stimulate cells of the INL into the G1-S transition of
the cell cycle either for proliferation or apoptosis. We are currently using the genetic
background offered by the BXD RI mouse strains to determine the role of the Chromosome
12 locus and ID2 in retinal wound healing. We have confirmed the variability of ID2 at the
transcript and protein level in retinas of BXD RI mouse strains (data not shown). We are using
high and low Id2 expressers to see the effect of Id2 dose effect on wound healing events
following retinal trauma.
The novel combination of microarray analysis, expression genetics, and bioinformatics
provides a new and powerful approach to defining regulatory elements in the genome. Using
this approach, we were able to generate specific, testable hypotheses defining pathways that
regulate proliferative and reactive responses in the retina and elsewhere in the CNS. As more
diverse gene expression data sets become available, it is our belief that comparison of gene
expression and regulation in different biological contexts will help identify the regulatory
elements controlling the reactive response in the retina.
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Figure 1.
Acute phase genes are modulated by distinct regulatory loci. We used the genetic analysis of
transcript expression at GeneNetwork to define genomic loci that control transcript abundance
variability in mouse brains. At the heart of this analysis is a unique population of mice, the
recombinant inbred (RI) strains of mice. One group of mice were derived by inbreeding for
over 20 generations the F1 crosses between C57BL/6 and DBA/2J mouse strains. Each BXD
RI strain has a shuffled genome consisting of a unique recombination of the C57BL/6 and
DBA/2J genomes, forming a segregating population of mice. These RI mouse strains, the
associated microarray databases, and the genetic-analysis tools at GeneNetwork allow one to
explore regulatory loci and networks built around any transcript [9–12]. The best way to think
about the genetic linkage mapping is at the transcript level. If there is specific variability in
transcript abundance among members of a segregating population, then it is possible to map
transcript abundance to a specific chromosomal locus. Genetic linkage maps show that a group
of acute phase genes is controlled by a regulatory locus on Chromosome 12. A: Individual
genome-wide maps for Id2 and Fos display linkage of transcript variability (y-axis) to loci
across the mouse genome (x-axis). Genetic analysis of transcript data from brain tissue was
determined in a panel of BXD recombinant inbred (RI) mouse strains [9,11]. Maps were
generated by linking transcript variability against 779 genetic markers that are interspaced
along the mouse genome by an average of 4 Megabase pairs (Mb). The alternating white and
blue columns represent chromosomes. The linkage between transcript variation and genetic
differences at a particular genetic locus is measured in terms of likelihood ratio statistic (LRS;
solid blue line). Dashed horizontal lines mark transcript-specific significance thresholds for
genome-wide p<0.05 (significant, blue) and genome-wide p<0.63 (suggestive, green). Orange
triangle indicates gene location. B: Multiple parallel genome-wide maps display linkage using
color hues with yellow and red bands representing suggestive and significant LRS. A common
regulatory locus on Chromosome 12 is identified for selected acute phase genes. Within this
locus, there is a genomic element modulating the expression of acute phase genes such as
Fos, Junb, and Egr1. Individual and multiple genome-wide maps were generated using the
tools at GeneNetwork. Orange triangles indicate gene location. Linkage maps were generated
using the Interval Mapping and Cluster Tree tools at GeneNetwork (UTHSC Brain mRNA
U74Av2 HWT1PM; December 2003).
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Figure 2.
Genetic networks controlling acute phase transcripts. Genetic networks were derived from
transcripts sharing regulatory loci in mouse brains. As shown in Figure 1, acute phase
transcripts Fos, Egr1, Nr4a1, Junb, Stat3, Id2, Crem, Ptpn16, and Scya3 are controlled by a
genomic locus on Chromosome 12. We also showed in Table 2 that these transcripts are part
of a common phase response to injury in retina, brain, and spinal cord. Transcripts genetically
linked to the same regulatory loci and highly regulated in injured CNS are hypothesized to be
part of a genetic network. In this diagram, lines connecting specific genes to loci represent a
correlation between transcript expression and the regulatory locus. The diagram also illustrates
two networks controlled by genomic loci on Chromosomes 6 and 14.
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Figure 3.
Evaluating candidate genes within Chromosome 14 locus. A: The transcript variability of
Adfp, Scya2, Irf1, Nfkb1, Il1b, Stat3, and Cxcl10 in brains from BXD RI mouse strains is
genetically linked to a regulatory locus on Chromosome 14. This network was generated by
comparing genome-wide scans that measure the linkage of transcript variability across the
mouse genome, as described in Figure 1. These transcripts are also upregulated as acute phase
transcripts in retina, brain and spinal cord (Table 2). Transcripts genetically linked to the same
regulatory loci and highly regulated in injured CNS are hypothesized to be part of a genetic
network. B: The combined genome-wide map shows that their transcript expression has a
strong genetic linkage to a locus within Chromosome 14. The genome wide scan, zoomed at
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Chromosome 14, shows the genetic linkage (y-axis, likelihood ratio statistic [LRS]) across the
chromosome (x-axis, Megabase pairs [Mb]). The locus (35 to 65 Mb) includes 315 genes, some
of which have a high or low single nucleotide polymorphism (SNP) density. SNP density is
denoted by the height of the orange lines on the x-axis. Several rules may help in selecting
candidate gene responsible for this regulatory locus. The first rule is there have to be SNPs
present within the coding or regulatory region of the gene of interest. As a first approximation
we used SNP density that is displayed at the bottom of panel B and D. The second rule is a
high degree of transcript abundance variability in the BXD RI strains (illustrated in C). C:
Transcript abundance variability in normal forebrains of BXD RI mouse strains is due to
genetic polymorphisms between the parental C57BL/6 and DBA/2J mouse strains. The graph
illustrates transcript abundance variability (y-axis) for genes (dots) within the 35 to 65 Mb
interval of Chromosome 14 (x-axis). For a transcript to be mapped its abundance must vary
across the BXD RI mouse strains. The higher the variation in transcript abundance the more
likely that the gene is a candidate. Furthermore we expect that the variability is due to a
polymorphism in the candidate gene, suggesting that the polymorphic gene is modulating its
own expression level (that is, a “cis-regulatory locus”). We measured transcript variability
using an analysis of variance (ANOVA) that tests the between-strain variance compared with
the total variance for 100 arrays from 35 mouse strains. The degrees of freedom for the between-
group and total variance are 34 and 99. Strain-specific variation is significant (p<0.05) when
F34,99>1.5. In the graph, each dot represents a gene with its variability measured by the
ANOVA F-statistic (y-axis) and its genomic location within Chromosome 14 described in Mb.
Rnase4, AW045965, M6a, Boct, Dad1, Ctsb, Cnih, and Ndrg2 are polymorphic genes that
displayed significant transcript variability and cis-regulatory loci in normal forebrains of BXD
mouse strains. D: The third criterion identifies the genes that display self regulation across
CNS tissues. For example, the transcript variability of Ndrg2 (red circle in C) displayed a cis-
regulatory locus in brain (LRS=38, probe set 96088_at) and cerebellum (LRS=13, probe set
1448154_at_A) of BXD RI mouse strains. Here we illustrate linkage of Ndrg2 transcript
variability in BXD RI mouse strains across Chromosome 14. Red triangle indicates gene
location. Rnase4, AW045965, and M6a also displayed cis-regulatory loci in brain and
cerebellum (data available at GeneNetwork). E: The fourth criterion deals with the biology of
the system. Meta-analyses of transcript levels during retinal development and retinal injury
can help determine if a candidate gene is a potential regulator in the retina. For example in
murine models of retinal development, Ndrg2 displayed moderate transcript levels as early as
postnatal day 4 and was highly expressed in the adult retina. In contrast, Rnase4, AW045965,
and M6a were absent from birth through adult stages. Normalized expression data for Ndrg2
(y-axis) during murine retinal development (x-axis) is available at RetDevGE [21].
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Figure 4.
Evaluating candidate genes within Chromosome 6 locus. A: The transcript variability of
Scya2, Nfkb1, Fosl1, Timp1, Fos, Nr4a1, and Icam1 in brains from BXD RI mouse strains is
genetically linked to the regulatory locus on Chromosome 6. This network was generated by
comparing genome-wide scans that measure the linkage of transcript variability across the
mouse genome, as described in Figure 1. These transcripts are also upregulated as acute phase
transcripts in retina, brain and spinal cord (Table 2). Transcripts genetically linked to the same
regulatory loci and highly regulated in injured CNS are hypothesized to be part of a genetic
network. B: The combined genome-wide map shows that their transcript expression has a
strong genetic linkage to a locus within Chromosome 6, 105 to 132 Mb. The genome wide
scan, zoomed at Chromosome 6, shows the genetic linkage (y-axis, likelihood ratio statistic
[LRS]) across the chromosome (x-axis, Megabase pairs [Mb]). This locus includes over 200
positional genes, some of which have a high or low single nucleotide polymorphism (SNP)
density. SNP density is denoted by the height of the orange lines on the x-axis. Several rules
may help in selecting candidate gene responsible for this regulatory locus. The first rule is there
have to be SNPs present within the coding or regulatory region of the gene of interest. As a
first approximation we used SNP density that is displayed at the bottom of panel B and D. The
second rule is a high degree of transcript abundance variability in the BXD RI strains (illustrated
in C). C: Transcript abundance variability in normal forebrains of BXD RI mouse strains is
due to genetic polymorphisms between the parental C57BL/6 and DBA/2J mouse strains. The
graph illustrates transcript abundance variability (y-axis) for genes (dots) within the 105 to 132
Mb interval of Chromosome 6 (x-axis). The higher the variation in transcript abundance the
more likely that the gene is a candidate. Furthermore we expect that the variability is due to a
Vazquez-Chona et al. Page 18
Mol Vis. Author manuscript; available in PMC 2010 January 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
polymorphism in the candidate gene, suggesting that the polymorphic gene is modulating its
own expression level (that is, a “cis-regulatory locus”). We measured transcript variability
using an analysis of variance (ANOVA) that tests the between-strain variance compared with
the total variance for 100 arrays from 35 mouse strains. The degrees of freedom for the between-
group and total variance are 34 and 99. Strain-specific variation is significant (p<0.05) when
F34,99>1.5. In the graph, each dot represents a gene with its variability measured by the
ANOVA F-statistic (y-axis) and its genomic location within Chromosome 6 described in Mb.
Tulp3, Ccnd2, Tead4, and Atp2b2 are polymorphic genes that displayed significant transcript
variability and cis-regulatory loci in normal forebrains of BXD mouse strains. D: The third
criterion identifies the genes that display self regulation across CNS tissues. For example, the
transcript variability of Ccnd2 (red circle in C) displays a strong cis-regulatory locus in the
forebrain (LRS=25, probe set 97504_at) and cerebellum (LRS=14, probe set probe set
1416122_at_A) of BXD RI mouse strains. Here we illustrate linkage of Ccnd2 transcript
variability in BXD RI mouse strains across Chromosome 6. Red triangle indicates gene
location. Atp2b2, Tulp3, and Tead4 also displayed cis-regulatory loci in brain and cerebellum
(data available at GeneNetwork). The role of a candidate gene as a modulator of the
Chromosome 6 and wound healing is further strengthen if its transcript is differentially
expressed in injured CNS. Ccnd2 displays increased transcript levels in injured rat retina (data
available at GEO data set GSE1001, probe set rc_AA899106_at) [1].
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Figure 5.
Evaluating candidate genes within Chromosome 12 locus. A: The transcript variability of
Id2, Crem, Egr1, Fos, Nr4a1, Junb, Ptpn16, and Icam1 in brains from BXD RI mouse strains
is genetically linked to the regulatory locus on Chromosome 12. This network was generated
by comparing genome-wide scans that measure the linkage of transcript variability across the
mouse genome, as described in Figure 1. These transcripts are also upregulated as acute phase
transcripts in retina, brain and spinal cord (Table 2). Transcripts genetically linked to the same
regulatory loci and highly regulated in injured CNS are hypothesized to be part of a genetic
network. B: The combined genome-wide map shows that their transcript expression has a
strong genetic linkage to a locus within Chromosome 12, 10 to 30 Mb. The genome wide scan,
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zoomed at Chromosome 12, shows the genetic linkage (y-axis, likelihood ratio statistic [LRS])
across the chromosome (x-axis, Megabase pairs [Mb]). This locus includes over 60 positional
genes, some of which have a high or low single nucleotide polymorphism (SNP) density. SNP
density is denoted by the height of the orange lines on the x-axis. Several rules may help in
selecting candidate gene responsible for this regulatory locus. The first rule is there have to be
SNPs present within the coding or regulatory region of the gene of interest. As a first
approximation we used SNP density that is displayed at the bottom of panel B and D. The
second rule is a high degree of transcript abundance variability in the BXD RI strains (illustrated
in C). C: Transcript abundance variability in normal forebrains of BXD RI mouse strains is
due to genetic polymorphisms between the parental C57BL/6 and DBA/2J mouse strains. The
graph illustrates transcript abundance variability (y-axis) for genes (dots) within the 10 to 30
Mb interval of Chromosome 12 (x-axis). For a transcript to be mapped its abundance must vary
across the BXD RI mouse strains. The higher the variation in transcript abundance the more
likely that the gene is a candidate. Furthermore we expect that the variability is due to a
polymorphism in the candidate gene, suggesting that the polymorphic gene is modulating its
own expression level (that is, a “cis-regulatory locus”). We measured transcript variability
using an analysis of variance (ANOVA) that tests the between-strain variance compared with
the total variance for 100 arrays from 35 mouse strains. The degrees of freedom for the between-
group and total variance are 34 and 99. Strain-specific variation is significant (p<0.05) when
F34,99>1.5. In the graph, each dot represents a gene with its variability measured by the
ANOVA F-statistic (y-axis) and its genomic location within Chromosome 12 described in Mb.
Lpin1 and Id2 are polymorphic genes that displayed significant transcript variability and cis-
regulatory loci in normal forebrains of BXD mouse strains. D: The third criterion identifies
the genes that display self regulation across CNS tissues. For example, the transcript variability
of Id2 (red circle in C) displayed a cis-regulatory locus in the brain (LRS=44, probe set
93013_at) and cerebellum (LRS=14; 1453596_at_A) of BXD RI mouse strains. Here we
illustrate linkage of Id2 transcript variability in BXD RI mouse strains across Chromosome
12. Red triangle indicates gene location. Lpin1 also displayed cis-regulatory loci in brain and
cerebellum (data available at GeneNetwork). E: The structure of the Id2 gene illustrates a SNP
at the promoter region and four SNPs within the second intron. F: The SNP within the promoter
region (Ensembl SNPView ID rs4229289 and Celera SNP ID mC22302957) is located within
a highly conserved region and is adjacent to a nuclear transcription factor Y (NF-Y) binding
site (TRANSFAC ID M00185). Gene structure was obtained from Ensembl and
GenomeBrowser. The TRANSFAC 5.0 database was accessed through the MOTIF website.
Highly conserved regions were defined using the GenomeBrowser Conservation tool (Mouse
May 2004 Assembly).
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